These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11837468)

  • 1. Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study.
    Chugh SN; Dhawan R; Kishore K; Sharma A; Chugh K
    J Assoc Physicians India; 2001 Aug; 49():803-7. PubMed ID: 11837468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of oxidative stress in diabetes mellitus during uncontrolled and controlled state and after vitamin E supplementation.
    Chugh SN; Kakkar R; Kalra S; Sharma A
    J Assoc Physicians India; 1999 Apr; 47(4):380-3. PubMed ID: 10778519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide].
    Jennings PE; Belch JJ
    Ter Arkh; 2001; 73(4):27-31. PubMed ID: 11494442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of gliclazide and left ventricular mass in type 2 diabetic patients.
    Pan NH; Lee TM; Lin MS; Huang CL; Chang NC
    Diabetes Res Clin Pract; 2006 Nov; 74(2):121-8. PubMed ID: 16631274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
    Kardas P
    Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes.
    Räkel A; Renier G; Roussin A; Buithieu J; Mamputu JC; Serri O
    Diabetes Obes Metab; 2007 Jan; 9(1):127-9. PubMed ID: 17199728
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress--a prospective preliminary study.
    Jain S; Gaiha M; Bhattacharjee J; Anuradha S
    J Assoc Physicians India; 2002 Aug; 50():1028-33. PubMed ID: 12421024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A prospective randomized study of sulphonylureas therapeutic interchange in patients with type 2 diabetes mellitus].
    Crespí Monjo M; Delgado Sánchez O; Ventayol Bosch P; Lafuente Fló A; Pinteño Blanco M; Escrivá Torralva A; Puigventós Latorre F; Martínez-López I
    Farm Hosp; 2004; 28(6):426-32. PubMed ID: 15628945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects.
    Formoso G; De Filippis EA; Michetti N; Di Fulvio P; Pandolfi A; Bucciarelli T; Ciabattoni G; Nicolucci A; Davì G; Consoli A
    Diabetes Metab Res Rev; 2008; 24(3):231-7. PubMed ID: 17966969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients.
    Wascher TC; Boes U
    Clin Physiol Funct Imaging; 2005 Jan; 25(1):40-6. PubMed ID: 15659079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
    Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ineffectiveness of allopurinol in reduction of oxidative stress in diabetic patients; a randomized, double-blind placebo-controlled clinical trial.
    Afshari M; Larijani B; Rezaie A; Mojtahedi A; Zamani MJ; Astanehi-Asghari F; Mostafalou S; Hosseinnezhad A; Heshmat R; Abdollahi M
    Biomed Pharmacother; 2004 Dec; 58(10):546-50. PubMed ID: 15589061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of short-term glycemic regulation with gliclazide and metformin on postprandial lipemia.
    Emral R; Köseoğlulari O; Tonyukuk V; Uysal AR; Kamel N; Corapçioğlu D
    Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):80-4. PubMed ID: 15772898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes.
    Chen LL; Yu F; Zeng TS; Liao YF; Li YM; Ding HC
    Eur J Pharmacol; 2011 Jun; 659(2-3):296-301. PubMed ID: 21453695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.
    Matthews DR; Charbonnel BH; Hanefeld M; Brunetti P; Schernthaner G
    Diabetes Metab Res Rev; 2005; 21(2):167-74. PubMed ID: 15386821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality.
    Monami M; Balzi D; Lamanna C; Barchielli A; Masotti G; Buiatti E; Marchionni N; Mannucci E
    Diabetes Metab Res Rev; 2007 Sep; 23(6):479-84. PubMed ID: 17385195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
    Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C
    Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.